Evidence map›Paper›PMID 32483223›Full record

ArticleNature communications2020

Machine learning uncovers cell identity regulator by histone code.

Bo Xia, Dongyu Zhao, Guangyu Wang, Min Zhang, Jie Lv, Alin S Tomoiaga, Yanqiang Li, Xin Wang, Shu Meng, John P Cooke and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Bo Xia *Center for Bioinformatics and Computational Biology, Houston Methodist Research Institute, Houston, TX, USA.
Dongyu Zhao *Center for Bioinformatics and Computational Biology, Houston Methodist Research Institute, Houston, TX, USA.
Guangyu Wang *Center for Bioinformatics and Computational Biology, Houston Methodist Research Institute, Houston, TX, USA.
Min ZhangCenter for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, USA.
Jie LvCenter for Bioinformatics and Computational Biology, Houston Methodist Research Institute, Houston, TX, USA.
Alin S TomoiagaBusiness Analytics, CIS & Law Department, The O'Malley School of Business Accounting, Manhattan College, Riverdale, NY, USA.
Yanqiang LiCenter for Bioinformatics and Computational Biology, Houston Methodist Research Institute, Houston, TX, USA.ORCID http://orcid.org/0000-0003-3515-0140
Xin WangCenter for Bioinformatics and Computational Biology, Houston Methodist Research Institute, Houston, TX, USA.ORCID http://orcid.org/0000-0003-1456-335X
Shu MengCenter for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, USA.
John P CookeCenter for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, USA.
Qi CaoDepartment of Urology, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA. qi.cao@northwestern.edu.ORCID http://orcid.org/0000-0002-5140-3681
Lili ZhangCenter for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, USA. lzhang3@houstonmethodist.org.
Kaifu ChenCenter for Bioinformatics and Computational Biology, Houston Methodist Research Institute, Houston, TX, USA. kchen2@houstonmethodist.org.ORCID http://orcid.org/0000-0003-1009-4357

Funding

Targeting FOXA1-downstream pathways: a novel therapeutic strategy for castration-resistant prostate cancerP50CA180995 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ABDULKADIR, SARKI A., HUSSAIN, MAHA H · 2015 to 2025
$19.9M
Reversal of Heart Failure: Role of Vascular RecoveryR01HL148338 · NHLBI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI CHEN, KAIFU, COOKE, JOHN P · 2020 to 2023
$2.8M
The inhibitory network between EZH2 and PARP1 in triple-negative breast cancerR01CA208257 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CAO, QI · 2017 to 2022
$1.8M
Role of S-nitrosylation in TransdifferentiationR01HL133254 · NHLBI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI CHEN, KAIFU, COOKE, JOHN P · 2018 to 2021
$1.6M
Computational epigenetics modeling of cell identity genesR01GM125632 · NIGMS · METHODIST HOSPITAL RESEARCH INSTITUTE · PI CHEN, KAIFU · 2018 to 2021
$1.4M
NCI NIH HHS P50 CA180995NCI NIH HHS R01 CA208257NHLBI NIH HHS R01 HL133254NHLBI NIH HHS R01 HL148338NIGMS NIH HHS R01 GM125632
6 · The paper itself

Abstract

Conversion between cell types, e.g., by induced expression of master transcription factors, holds great promise for cellular therapy. Our ability to manipulate cell identity is constrained by incomplete information on cell identity genes (CIGs) and their expression regulation. Here, we develop CEFCIG, an artificial intelligent framework to uncover CIGs and further define their master regulators. On the basis of machine learning, CEFCIG reveals unique histone codes for transcriptional regulation of reported CIGs, and utilizes these codes to predict CIGs and their master regulators with high accuracy. Applying CEFCIG to 1,005 epigenetic profiles, our analysis uncovers the landscape of regulation network for identity genes in individual cell or tissue types. Together, this work provides insights into cell identity regulation, and delivers a powerful technique to facilitate regenerative medicine.

Indexed as

Histone CodeMachine LearningAlgorithmsCellsChromatin Immunoprecipitation SequencingDatabases, GeneticEpigenesis, GeneticGene Expression RegulationGene Regulatory NetworksHumansHuman Umbilical Vein Endothelial CellsPhenotypePluripotent Stem CellsRegenerative MedicineRNA-SeqTranscription FactorsTranscription Factors

Identifiers

PMID32483223
PMCPMC7264183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.